Aussie Melanoma Vaccine Shows Promise In Early-Stage Trial
This article was originally published in PharmAsia News
Executive Summary
Australia researchers say an advanced melanoma vaccine has shown promise in an early-stage trial for extending survival of patients, one beyond 10 years.